These medications slow gastric emptyingthe rate at which food leaves your stomachwhich creates prolonged satiety and reduces caloric intake
Novo Nordisk is cited as either a sponsor or collaborator 112 times and as a collaborator 21 times in the dataset
The most common experiences include slight nausea (particularly with first doses), minor fatigue or drowsiness, temporary dizziness, injection site reactions like mild redness or itching, and sleep disturbances (usually with evening dosing)
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are naturally occurring hormones that regulate appetite, insulin secretion, and metabolism
Most patients see meaningful improvement after completing 3 cycles, roughly three months of consistent treatment
[63] Research continued, and in 1993, Michael Nauck managed to infuse GLP-1 into people with type 2 diabetes, stimulating insulin while inhibiting glucagon and bringing blood glucose to normal levels